Outcomes for liver transplant candidates listed with low model for end‐stage liver disease score

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|21|11|1403-1409

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.11, 2015-11, pp. : 1403-1409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Keeping high model for end‐stage liver disease score liver transplantation candidates alive

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 11, 2015-11 ,pp. : 1428-1437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival outcomes in liver transplant recipients with Model for End‐stage Liver Disease scores of 40 or higher: a decade‐long experience

By  

HPB, Vol. 17, Iss. 12, 2015-12 ,pp. : 1074-1084

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1643-1650

John Wiley & Sons Inc

Access to resources Recommend Favorite

High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of end‐stage liver disease

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 7, 2015-07 ,pp. : 881-888

John Wiley & Sons Inc

Access to resources Recommend Favorite

C‐reactive protein and model for end‐stage liver disease score: Have we found the fifth element?

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 713-715

John Wiley & Sons Inc

Access to resources Recommend Favorite